
USD
$0.00
(0.00%
)At Close (As of Dec 16, 2025)
$2.32M
Market Cap
0.0163
P/E Ratio
187.66
EPS
$84.40
52 Week High
$2.91
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$340K |
| Total Revenue | $0 |
| Cost Of Revenue | $340K |
| Costof Goods And Services Sold | $340K |
| Operating Income | -$9.3M |
| Selling General And Administrative | $9.3M |
| Research And Development | $2.2M |
| Operating Expenses | $9.3M |
| Investment Income Net | - |
| Net Interest Income | $288K |
| Interest Income | $298K |
| Interest Expense | $10K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $340K |
| Income Before Tax | -$13M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$13M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$13M |
| Ebitda | -$13M |
| Net Income | -$13M |
| Field | Value (USD) |
|---|---|
| Total Assets | $7.4M |
| Total Current Assets | $5.9M |
| Cash And Cash Equivalents At Carrying Value | $5.5M |
| Cash And Short Term Investments | $5.5M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $1.4M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $550 |
| Intangible Assets Excluding Goodwill | $550 |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $449K |
| Other Non Current Assets | - |
| Total Liabilities | $2.2M |
| Total Current Liabilities | $1.9M |
| Current Accounts Payable | $535K |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $313K |
| Total Non Current Liabilities | $337K |
| Capital Lease Obligations | $650K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $650K |
| Other Current Liabilities | $1.1M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $5.1M |
| Treasury Stock | - |
| Retained Earnings | -$168M |
| Common Stock | $2.6K |
| Common Stock Shares Outstanding | $156K |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$340K |
| Total Revenue | $0 |
| Cost Of Revenue | $340K |
| Costof Goods And Services Sold | $340K |
| Operating Income | -$9.3M |
| Selling General And Administrative | $9.3M |
| Research And Development | $2.2M |
| Operating Expenses | $9.3M |
| Investment Income Net | - |
| Net Interest Income | $288K |
| Interest Income | $298K |
| Interest Expense | $10K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $340K |
| Income Before Tax | -$13M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$13M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$13M |
| Ebitda | -$13M |
| Net Income | -$13M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Aethlon Medical, Inc. (AEMD) is a pioneering medical technology company based in San Diego, California, specializing in the development of innovative solutions for the diagnosis and treatment of life-threatening diseases. Leveraging a proprietary platform, Aethlon targets critical unmet medical needs with its advanced therapeutic products, aiming to significantly enhance patient outcomes. The company's strategic focus on research and development positions it as a formidable entity in the medical technology landscape, driving progress in the rapidly evolving healthcare sector amidst growing demand for effective interventions.